Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia

被引：0
|
作者：
Tanner, Michael [1 ]
机构：
[1] NYU, Sch Med, New York, NY 10016 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2016年 / 165卷 / 04期
关键词：
D O I：
10.7326/ACPJC-2016-165-4-020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC20 / JC20
页数：1
相关论文
共 50 条
  • [21] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    Reaven, Peter
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 154 - 163
  • [22] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Lerch, C. L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [23] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
    Lizan, L.
    Aceituno, S.
    Franch, J.
    Perez, A.
    Granell, M.
    Fuster, E.
    VALUE IN HEALTH, 2014, 17 (07) : A348 - A348
  • [24] Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
    Richard, Kathleen R.
    Shelburne, Jamie S.
    Kirk, Julienne K.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1609 - 1629
  • [25] Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
    Chatterjee, Saurav
    Chatterjee, Sanjay
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (08)
  • [26] DIPEPTIDYL PEPTIDASE-4 INHIBITORS, SULPHONYLUREAS, AND HYPOGLYCAEMIA Under-representation of frail older people in meta-analysis of dipeptidyl peptidase-4 inhibitors and hypoglycaemia
    Tufan, Fatih
    Soyluk, Ozlem
    Bahat, Gulistan
    Karan, Mehmet Akif
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [27] Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
    Driessen, Johanna H. M.
    van Onzenoort, Hein A. W.
    Henry, Ronald M. A.
    Lalmohamed, Arief
    van den Bergh, Joop P.
    Neef, Cees
    Leufkens, Hubert G. M.
    de Vries, Frank
    BONE, 2014, 68 : 124 - 130
  • [28] Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Esaki, Hiroki
    Tachi, Tomoya
    Goto, Chitoshi
    Sugita, Ikuto
    Kanematsu, Yuta
    Yoshida, Aki
    Saito, Kosuke
    Noguchi, Yoshihiro
    Ohno, Yuki
    Aoyama, Satoshi
    Yasuda, Masahiro
    Mizui, Takashi
    Yamamura, Masumi
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [29] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
    Deacon, Carolyn F.
    Holst, Jens J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2047 - 2058
  • [30] Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
    Meng, Jie
    Yan, Rui
    Zhang, Chen
    Bai, Xueyan
    Yang, Xingsheng
    Yang, Yu
    Feng, Tao
    Liu, Xin
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
12345